Vimab Group AB (publ) (STO:VIMAB)
2.250
-0.050 (-2.17%)
Nov 20, 2026, 5:25 PM CET
| Market Cap | 107.01M +1.8% |
| Revenue (ttm) | 339.49M +5.6% |
| Net Income | -84.42M |
| EPS | -3.71 |
| Shares Out | 47.56M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 29,437 |
| Open | 2.300 |
| Previous Close | 2.300 |
| Day's Range | 2.170 - 2.300 |
| 52-Week Range | 1.790 - 5.500 |
| Beta | -1.15 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Mar 12, 2027 |